Skip to main
University-wide Navigation

Markey’s ACTION program gets $2 million grant renewal from NCI

Launched in 2016, ACTION is a cancer education and training program aimed at high school and undergraduate students from Appalachian Kentucky.

UK researchers’ new study focuses on preventing deaths of pregnant women

A team of researchers at the University of Kentucky is working to reduce the number of deaths and injuries among pregnant and postpartum women through an online training program for UK students in helping professions across nine UK colleges.

WIMS Day 2023

Join us for WIMS Day! Thursday, Oct. 12, 2023 Noon to 5:30 p.m. Healthy Kentucky Research Building 150/Atrium  This event will feature a keynote by Dr. Mary Dankoski at noon, both virtually and in-person. Lunch will be provided for in-person attendees.  Following the keynote, there will be an interactive workshop on professional development between 1:30 p.m. to 3 p.m. (In-person only) At 3:30 p.m., WIMS 2022 Booster Award winners will present their research. (In-person only)

Alliance Research Initiative Event

Join the College of Medicine as we celebrate milestones for our Alliance Research Initiative teams! The following groups will be on site to provide resources and information: Proposal Development Office (PDO) Center for Clinical and Translational Science (CCTS) College of Medicine medical illustrators UK Innovate Undergraduate Research Philanthropy 

Markey Cancer Center attains NCI's highest status as a Comprehensive Cancer Center

The University of Kentucky Markey Cancer Center announced today that it has earned a National Cancer Institute “Comprehensive” Cancer Center designation, the highest level of recognition awarded by the NCI.

Cardiovascular Research Day

October 20, 2023 Central Bank Center Grand Ballrooms 430 W. Vine Street Lexington KY 40507 Full Schedule (pdf)

UK researchers 1st to show multiple sclerosis drug can be used as Alzheimer’s therapy

A team of researchers at the University of Kentucky has found that a drug used to treat multiple sclerosis (MS) is potentially effective as a therapy for Alzheimer’s disease.

HEAL expands naloxone access to turn the tide on overdose deaths

Aug. 31 marks International Overdose Awareness Day, a time when attention is directed toward raising awareness about opioid overdose and ways to reverse deadly effects. One such way is naloxone, which has become more available throughout Kentucky due to UK’s HEALing Communities Study.

In Hinds Lab, trainees gain experience with cutting-edge research

The lab of Terry Hinds, Ph.D., is advancing scientific discovery at UK, and also helping undergraduate students, graduate students and postdoctoral fellows gain early experience with high-impact work.

Tiny antibodies hold big promise for cancer treatment

Using antibodies derived from alpacas, a University of Kentucky research team has developed a tool that could lead to new therapies to stop the growth of several types of cancer.